17 min ago
BATTLER: Brave East Lancs boy helping others to face cancer
Rieli Biggins, nine, underwent three years of chemotherapy to help overcome the acute lymphoblastic leukaemia he was diagnosed with at the age of three.
Trending on the Topix Network
Wed Jul 09, 2014
BiOsimilaRs in the management of anaemia secondary to chemotherapy in ...
The approval of epoetin biosimilars in the European Union requires extensive scientific evaluation and stringent regulatory procedures, including post-marketing studies.
Targeted therapeutics in treatment of children and young adults with...
Targeted therapeutics in treatment of children and young adults with solid tumors: an expert survey and review of the literature.
Program to help "forgotten" teen cancer patients
Better treatments and screenings are helping children and older adults with cancer live longer.
Los Angeles Times
Keck Medicine pushing into O.C. with oncology network acquisition
Keck Medicine of USC has acquired an oncology business as part of an expansion into Orange County.
Medical News Today
New test predicts survival and disease progression in blood cancer patients
Researchers from Cardiff University's School of Medicine used pioneering techniques for measuring the length and function of tiny structures known as 'telomeres' - repeating sections of DNA found at the ends of chromosomes.
Tue Jul 08, 2014
Personalized Cell Therapy CTL019 Receives FDA - Breakthrough Therapy' Designation
The FDA has granted "breakthrough therapy" status to CTL019 , an investigational chimeric antigen receptor therapy for the treatment of pediatric and adult patients with relapsed or refractory acute lymphoblastic leukemia .
Health Aware: Aurora woman takes action against high cancer risk
Based on her own extensive experience being treated for and attempting to prevent cancer, Sheila Tucker strongly urges people to learn their family history, make time to see their doctor, stay on schedule with mammograms and other screenings, and take advantage of genetic testing.
Boehringer Ingelheim Corporation's Volasertib Phase 2 Data Including...
Volasertib has not been approved by the FDA; its safety and efficacy have not been established.
The Daily Record
New cancer fighting jag could help thousands of Scottish patients gain better quality of life
THOUSANDS of Scots cancer patients could have a better quality of life after a radical A treatment was approved yesterday.
Mon Jul 07, 2014
FDA Approves Novo Nordisk A/S's NovoSeven?? RT To Treat Glanzmann's...
Glanzmann's Thrombasthenia is a rare genetic bleeding disorder with limited treatment options.
FDA Grants Spectrum Pharmaceuticals, Inc. Accelerated Approval Of...
Spectrum Pharmaceuticals , a biotechnology company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, announced today that the U.S. Food and Drug Administration has granted Accelerated Approval of Beleodaqa for the treatment of patients with relapsed or refractory peripheral T-cell ... (more)
The Summerville Journal-Scene
Robert Silgals, MD
Dr. Robert Silgals has cared for Lowcountry patients who have cancer and blood disorders for almost 29 years.
Medical News Today
FDA approves Beleodaq to treat rare, aggressive form of non-Hodgkin lymphoma
The U.S. Food and Drug Administration has approved Beleodaq for the treatment of patients with peripheral T-cell lymphoma , a rare and fast-growing type of non-Hodgkin lymphoma .
Sun Jul 06, 2014
IVD Market 2018: Increased Adoption of POC Diagnostic Tests is a Key...
IVD Market 2018: Increased Adoption of POC Diagnostic Tests is a Key Trend, Says New Research Report at Sandlerresearch.org In the recent past, there has been an increased adoption of POC diagnostic tests by patients.
Sat Jul 05, 2014
Innovation partnership to unlock the potential of e-health
Patients in the Waitemata district will ultimately benefit from improved health outcomes under an agreement to develop new e-health initiatives between Waitemata DHB and New Zealand-owned global health software company Orion Health.
Fri Jul 04, 2014
FDA accelerates approval of Beladoaq to treat peripheral T-cell lymphoma
Beleodaq just received FDA approval for the for the treatment peripheral T-cell lymphoma , a rare and fast-growing type of non-Hodgkin lymphoma .
Thu Jul 03, 2014
FDA Green Lights Spectrum Pharmaceuticals, Inc.'s Beleodag To Treat Rare Form Of Lymphoma
FDA approves Beleodaq to treat rare, aggressive form of non-Hodgkin lymphoma The U.S. Food and Drug Administration today approved Beleodaq for the treatment of patients with peripheral T-cell lymphoma , a rare and fast-growing type of non-Hodgkin lymphoma .
Malaysian National News Agency
Vietnam Launches Cross-Country Blood Donation Campaign
A cross-country blood donation campaign was launched in Rach Gia city in southern province of Kien Giang on Thursday, Vietnam News Agency reported.
Wed Jul 02, 2014
Research and Markets: Impact of US Healthcare Reform on the In Vitro Diagnostics Market 2014
This Market Insight highlights the effects of the US Patient Protection and Affordable Care Act on the in vitro diagnostics market, diagnostic test service providers, and IVD manufacturers.